February 26, 2021February 24, 2021
A Farewell Note to My Beloved Readers
Columns, Life After Lymphoma: A Young Warrior's Guide to Recovery - a Column by Michelle Raphaella Fredman
So, the time has come. Here I am, three years after I sat down for the first time to write ... Read more
February 15, 2021February 11, 2021
A Light-giver Shares a Lesson in Emotional Honesty
Columns, Life After Lymphoma: A Young Warrior's Guide to Recovery - a Column by Michelle Raphaella Fredman
Have you ever noticed how the people with the most light to give are often those who have endured the ... Read more
February 1, 2021January 27, 2021
Embarking on a New Chapter While Cherishing the Value of Community
Columns, Life After Lymphoma: A Young Warrior's Guide to Recovery - a Column by Michelle Raphaella Fredman
It’s surreal to ponder that our world has been living through a pandemic for a year now. That we’ve endured ... Read more
December 14, 2020December 9, 2020
Shedding My Sickness While Acknowledging Its Eternal Impact
Columns, Life After Lymphoma: A Young Warrior's Guide to Recovery - a Column by Michelle Raphaella Fredman
Just before the world changed overnight in March, I wrote a column titled “The Paradox of Healing.” In it, I ... Read more
November 16, 2020November 12, 2020
Sometimes Everything Works Out All Right
Columns, Life After Lymphoma: A Young Warrior's Guide to Recovery - a Column by Michelle Raphaella Fredman
The other day, I chanced upon a poem called “Sometimes” that stopped me in my tracks and penetrated right through ... Read more
September 28, 2020September 24, 2020
Let’s Not Forget the Superheroes
Columns, Life After Lymphoma: A Young Warrior's Guide to Recovery - a Column by Michelle Raphaella Fredman
Lately, in the midst of all the insanity going on in the world and the ensuing, albeit dispiriting, headlines covering ... Read more
September 14, 2020September 10, 2020
Frozen Toes and Sleepless Nights: The Reality of Being a Cancer Survivor
Columns, Life After Lymphoma: A Young Warrior's Guide to Recovery - a Column by Michelle Raphaella Fredman
For the past week, I have been living in what I can only describe as a state of unrelenting exhaustion. ... Read more
August 31, 2020August 27, 2020
Can a Break From Routine Induce Healing?
Columns, Life After Lymphoma: A Young Warrior's Guide to Recovery - a Column by Michelle Raphaella Fredman
This is a question I found myself pondering the other week as I locked up my little flat and escaped ... Read more
August 17, 2020August 13, 2020
Reflections on My ‘Re-birthday’ and the Past Year of Recovery
Columns, Life After Lymphoma: A Young Warrior's Guide to Recovery - a Column by Michelle Raphaella Fredman
By the time this column is published, the one-year anniversary of my lifesaving stem cell transplant will have come and ... Read more
July 27, 2020July 23, 2020
This Year Has Taught Me Gratitude
Columns, Life After Lymphoma: A Young Warrior's Guide to Recovery - a Column by Michelle Raphaella Fredman
This week I’ve felt completely at a loss over what to write about. It happens sometimes. Usually there’s something on ... Read more
July 13, 2020July 9, 2020
Total Happiness Is Unobtainable, and That’s OK
Columns, Life After Lymphoma: A Young Warrior's Guide to Recovery - a Column by Michelle Raphaella Fredman
I recently came to the realization that none of us will ever be totally happy. Upbeat way to start a ... Read more
June 29, 2020June 25, 2020
As I Befriend My Fear of Relapse, Fear Loses Its Power
Columns, Life After Lymphoma: A Young Warrior's Guide to Recovery - a Column by Michelle Raphaella Fredman
Being a cancer survivor is a complicated thing. It’s a lot of conflicting experiences at once. It’s walking down the ... Read more

December 14, 2017December 14, 2017

5-Year Survival Rates Promising for MTLC Patients Treated with Adcetris in Phase 1 Trial

News

Seattle Genetics reported promising five-year survival results from its Phase 1 clinical trial of Adcetris (brentuximab vedotin) in mature T-cell lymphoma (MTCL), also known as peripheral T-cell lymphoma. The findings ... Read more

December 14, 2017December 14, 2017

Is My History of Cancer a Disability in the Workplace?

Columns, Overcoming Adversity- a Column by Radiant Racheli

After being diagnosed with lymphoma, I had to put my schooling and career as a nanny on hold. A little past halfway through treatment, I had the epiphany to change ... Read more

December 13, 2017

40% of Relapsed NHL Patients Remain Cancer-free a Year After Treatment with Kite’s Yescarta

News

More than a year after receiving the CAR T-cell therapy Yescarta (axicabtagene ciloleucel), 42 percent of the patients in the ZUMA-1 trial are still responding to the treatment, Kite Pharma announced. The Phase ... Read more

December 12, 2017December 12, 2017

Immune Response to Reactive Herpes Virus Tied to Graft-versus-host Disease in Transplant Patients in Study

News

The immune system’s response to reactivated human cytomegalovirus (hCMV) infection, a form of herpes virus, has been linked to the onset of graft-versus-host disease (GVHD). The discovery, made by a ... Read more

December 11, 2017

Aptevo to Launch Phase 2 Trial of Therapy Candidate for Peripheral T-cell Lymphoma

News

Aptevo Therapeutics, a biotech company developing new therapies for blood and lymph cancers, will soon launch a Phase 2 clinical trial to evaluate its monospecific antibody candidate, otlertuzumab, in patients ... Read more

December 8, 2017December 8, 2017

Phase 2 Trial Testing Gazyva Combo Regimens in Relapsed Follicular Lymphoma Now Enrolling Participants

News

Biopharmaceutical company TG Therapeutics and the National Cancer Institute’s SWOG have initiated a Phase 2 trial testing three Gazyva (obinutuzumab) regimens in patients with relapsed or refractory follicular lymphoma. The ... Read more

December 7, 2017

Polatuzumab Vedotin Addition Makes Stark Difference for DLBCL Patients, Studies Show

News

Adding the investigational treatment polatuzumab vedotin to a therapy of Bendeka (bendamustine) and Rituxan (rituximab) made patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL) respond better to the ... Read more

December 7, 2017June 17, 2018

How I Celebrate My Cancerversary

Columns, Overcoming Adversity- a Column by Radiant Racheli

Growing up, I was not extremely crazy about birthdays. Of course, I thought they were fun and a wonderful excuse to get together with some of my favorite people, but ... Read more

December 6, 2017December 6, 2017

TRPH-222 Shows Significant Anti-tumor Activity in Lymphoma Preclinical Models

News

An investigational antibody-drug conjugate, TRPH-222, effectively reduced tumor burden in mice with diffuse large B-cell lymphoma (DLBCL) and mantle cell lymphoma (MCL), and is well-tolerated in non-human primates, a new ... Read more

December 4, 2017December 4, 2017

Survey Helps Doctors Better Understand Therapy Choices by Chronic Lymphocytic Leukemia Patients

News

A survey of patients with chronic lymphocytic leukemia (CLL) about multiple treatment scenarios found that while their top priority is longest progression-free survival, they are willing to make sacrifices on ... Read more

December 1, 2017December 1, 2017

Eureka Technologies Receives FDA’s OK to Move T-cell Therapy into Clinical Trials

News

The U.S. Food and Drug Administration (FDA) has approved the T-cell therapy ET190L1-ARTEMIS to move into clinical trials for the treatment of relapsed and refractory CD19-positive non-Hodgkin’s lymphoma (NHL). Following the ... Read more

November 30, 2017

Leukemia & Lymphoma Society Invests $46M in Research Funding Worldwide

News

As part of its comprehensive research investment program, the Leukemia & Lymphoma Society (LLS) recently committed $46 million to fund the most innovative science looking for cures for blood cancers at ... Read more

A Farewell Note to My Beloved Readers

A Light-giver Shares a Lesson in Emotional Honesty

Embarking on a New Chapter While Cherishing the Value of Community

Shedding My Sickness While Acknowledging Its Eternal Impact

Sometimes Everything Works Out All Right

Let’s Not Forget the Superheroes

Frozen Toes and Sleepless Nights: The Reality of Being a Cancer Survivor

Can a Break From Routine Induce Healing?

Reflections on My ‘Re-birthday’ and the Past Year of Recovery

This Year Has Taught Me Gratitude

Total Happiness Is Unobtainable, and That’s OK

As I Befriend My Fear of Relapse, Fear Loses Its Power